相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence Estimates of Predicted Pathogenic COL4A3-COL4A5 Variants in a Population Sequencing Database and Their Implications for Alport Syndrome
Joel Gibson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Examination of the predicted prevalence of Gitelman syndrome by ethnicity based on genome databases
Atsushi Kondo et al.
SCIENTIFIC REPORTS (2021)
Newborn Screening for Fabry Disease in Northeastern Italy: Results of Five Years of Experience
Vincenza Gragnaniello et al.
BIOMOLECULES (2021)
Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup
Dominique P. Germain et al.
JOURNAL OF MEDICAL GENETICS (2020)
The mutational constraint spectrum quantified from variation in 141,456 humans
Konrad J. Karczewski et al.
NATURE (2020)
Estimated prevalence of mucopolysaccharidoses from population-based exomes and genomes
Pamella Borges et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants
Melissa P. Wasserstein et al.
GENETICS IN MEDICINE (2019)
Fabry Disease: prevalence of affected males and heterozygotes with pathogenic GLA mutations identified by screening renal, cardiac and stroke clinics, 1995-2017
Dana Doheny et al.
JOURNAL OF MEDICAL GENETICS (2018)
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing
Matthew B. Lanktree et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat
Elfrida R. Benjamin et al.
GENETICS IN MEDICINE (2017)
A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels
Yasutsugu Chinen et al.
HUMAN GENOME VARIATION (2017)
Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry
Christiane Auray-Blais et al.
CLINICA CHIMICA ACTA (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Novel G144D mutation of the GLA gene in a Chinese patient with Fabry disease
Hui Li et al.
JOURNAL OF DERMATOLOGY (2014)
Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
Jan Lukas et al.
PLOS GENETICS (2013)
α-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants
Aleksandra Siekierska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients
Kent Doi et al.
JOURNAL OF HUMAN GENETICS (2012)
Fabry disease
Dominique P. Germain
ORPHANET JOURNAL OF RARE DISEASES (2010)
Third French multidisciplinary meeting on Fabry disease
D. P. Germain
REVUE DE MEDECINE INTERNE (2010)
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2007)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease
K Mills et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Structural basis of Fabry disease
SC Garman et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Alternative splicing in the α-galactosidase A gene:: Increased exon inclusion results in the Fabry cardiac phenotype
S Ishii et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Patients with Fabry disease on dialysis in the United States
R Thadhani et al.
KIDNEY INTERNATIONAL (2002)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease
R Schiffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
